Swift Receives TGA Approval for Commercial Launch in Australia
25/APR/2019
Emblation has announced that the Swift® microwave system has received TGA approval, and is now available in Australia.
Briggate Medical Company, based in Melbourne, is the exclusive partner for Swift® in Australia. With more than 25 years in industry, Briggate Medical is a unique, family owned and managed company that specialises in supplying Australasia’s private, hospital-based and community Podiatrists.
Emblation CEO, Gary Beale, commented: “We’ve had a great deal of interest from the Australian clinical community since research using the Swift® device began in 2013, so it’s fantastic to finally deliver the first systems to the country. The support we’ve received from our commercial partners Briggate has been unparalleled, with their reputation and experience in the industry proving invaluable.”
For all Australian enquiries, please visit www.briggatemedical.com. . For enquiries in other countries, please visit our distributors page.
About Emblation
Emblation is a global leader in medical microwave technology, with a focus on radical innovation in the treatment of HPV infections, dermatology, cardiology, and oncology.
Established in the USA in 2007, the company relocated to Scotland the following year to continue research into novel microwave ablation products. The team is led by some of the world’s foremost medical microwave experts, with a wealth of experience in the design, development and manufacture of microwave applications for a range of medical fields. Emblation is committed to providing next generation solutions for today’s medical conditions.
Latest News
- Our revolutionary technology continues to banish verruca woes
- Swift leads to major business boom for foot clinic
- Over 100,000 Swift Treatments Carried Out Across the UK and Ireland
- Emblation shortlisted for two Ceed Annual Industry Awards
- Case Reports in Dermatology: Successful Treatment of Hard Corns in Two Patients Using Microwave Energy
- Microwaves: A Painless, Efficient New Treatment for Plantar Warts
- British Journal of Dermatology Publishes AK Research
- Foothealth 2019
- Emblation announces launch of Swift in the USA
- Emblation Announces Commercial Partnership with Saorsa Inc
- Swift System Shows "Significant Potential to offer Efficient Treatment of Actinic Keratosis"
- Emblation Announces FDA Clearance for Swift Microwave Ablation Syste
- Swift Receives TGA Approval for Commercial Launch in Australia
- Emblation 2018 Australia Tour
- Emblation to join Briggate Medical at 2018 VIC Podiatry Conference, Melbourne
- Emblation shortlisted for British Engineering Excellence Awards 2017
- Emblation awarded “Outstanding Performance Business” at 2017 Clacks Business Awards
- Emblation Shortlisted for “Outstanding Performance Business” Award
- Emblation shortlisted for UK "Technology Innovation" Award
- Australasian Podiatry Conference 2017
- Emblation Awarded 'Best New Product' for Swift at Made In Scotland Awards
- Emblation Shortlisted for Best New Product Award
- Emblation Tops Award-Winning 12 months with Scottish Life Science Award
- Discover Swift Seminar
- Emblation Receive 'Innovative Collaboration' Award
- Emblation featured in Leading Microwave Magazine
- College of Podiatry Annual Conference
- Emblation Named ‘Outstanding Performance Business’ at Annual Business Awards
- Swift Southern Launch Event | Saturday 6th February
- Swift Launch Promotion
- Canonbury Products Appointed Official UK Distributor (Podiatry)
- Dermatology Update & An Introduction To Dermoscopy
- Swift to Sponsor Dermatology Study Day Delivered by Leading Expert Dr Ivan Bristow
- APMA 2015
- BAD Annual Meeting 2015
- Australasian Podiatry Conference 2015
- Swift Official Launch
- Podcast: "The Game Changing Treatment and Technology to combat HPV Warts"